Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  renal cell carcinoma/CD40L RNA-transfected autologous dendritic cell vaccine AGS-003
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: AGS-003-007, NCI-2013-00717, 2012-000871-17, NCT01582672
A Rollover Protocol for Subjects Previously Treated With AGS-003
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: AGS-003-005, NCI-2011-03808, NCT01482949
Vaccine Therapy before Surgery in Treating Patients with Localized Kidney Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 250113, NCI-2014-01254, AGS-003-012, NCT02170389
Start Over